NCT04592393View on ClinicalTrials.gov

Pancreas Cancer Surveillance Using an Abbreviated MRI

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Pancreas Cancer
Interventions
DIAGNOSTIC_TEST

Abbreviated PB MRI

Annual non-contrast PB MRI.

GENETIC

Gene mutation test

K-ras and GNAS mutation test. Being performed once as a baseline test at the enrollment.

DIAGNOSTIC_TEST

Conventional follow-up

Any of followings: scheduled CECT, MRI, USG, EUS, tumor marker (CA 19-9) during the study period.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

National Research Foundation of Korea

OTHER

lead

Seoul National University Hospital

OTHER